Tower Research Capital LLC (Trc) Vbi Vaccines Inc Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$0.29 - $0.64 $6,706 - $14,800	-23,126 Reduced 38.39%	37,115 $11,000
Q4 2022 Feb 10, 2023	BUY	$0.38 - $22.5 $18,260 - $1.08 Million	48,053 Added 394.26%	60,241 $24,000
Q3 2022 Nov 10, 2022	SELL	$0.73 - $23.4 $9,012 - $288,896	-12,346 Reduced 50.32%	12,188 $9,000
Q2 2022 Aug 15, 2022	SELL	$0.66 - $1.81 $13,030 - $35,734	-19,743 Reduced 44.59%	24,534 $20,000
Q1 2022 May 12, 2022	BUY	$1.27 - $2.47 $6,948 - $13,513	5,471 Added 14.1%	44,277 $74,000
Q4 2021 Feb 14, 2022	BUY	$2.21 - $3.22 $17,434 - $25,402	7,889 Added 25.52%	38,806 $91,000
Q3 2021 Nov 15, 2021	SELL	$2.8 - $3.72 $11,984 - $15,921	-4,280 Reduced 12.16%	30,917 $96,000
Q2 2021 Aug 16, 2021	BUY	$2.61 - $4.17 $13,940 - $22,271	5,341 Added 17.89%	35,197 $118,000
Q1 2021 May 17, 2021	SELL	$2.91 - $4.32 $9,832 - $14,597	-3,379 Reduced 10.17%	29,856 $93,000
Q4 2020 Feb 16, 2021	SELL	$2.15 - $3.5 $362,775 - $590,565	-168,733 Reduced 83.54%	33,235 $91,000
Q3 2020 Nov 16, 2020	BUY	$2.77 - $6.17 $465,761 - $1.04 Million	168,145 Added 497.13%	201,968 $578,000
Q2 2020 Aug 13, 2020	BUY	$0.87 - $3.13 $29,426 - $105,865	33,823 New	33,823 $105,000
Q4 2019 Feb 07, 2020	SELL	$0.48 - $1.38 $52,361 - $150,540	-109,087 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$0.47 - $1.05 $48,042 - $107,329	102,219 Added 1488.34%	109,087 $52,000
Q2 2019 Aug 13, 2019	BUY	$0.65 - $2.12 $4,464 - $14,560	6,868 New	6,868 $8,000
Q1 2019 May 14, 2019	SELL	$1.54 - $2.01 $3,064 - $3,999	-1,990 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$1.22 - $2.41 $2,427 - $4,795	1,990 New	1,990 $3,000
Q3 2018 Nov 13, 2018	SELL	$1.75 - $2.93 $6,373 - $10,671	-3,642 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$2.75 - $3.85 $382 - $535	139 Added 3.97%	3,642 $10,000
Q1 2018 May 15, 2018	BUY	$3.5 - $4.47 $10,160 - $12,976	2,903 Added 483.83%	3,503 $12,000
Q4 2017 Feb 09, 2018	SELL	$3.29 - $5.03 $10,396 - $15,894	-3,160 Reduced 84.04%	600 $3,000
Q3 2017 Nov 14, 2017	BUY	$3.15 - $4.01 $11,844 - $15,077	3,760	3,760 $18,000

Others Institutions Holding VBIV

# of Institutions

Shares Held

688K

Call Options Held

Put Options Held

Frontier Wealth Management LLC Kansas City, MO

602K
Shares

$12,036
0.01% of portfolio
ETF Managers Group, LLC Summit, NJ

85.7K
Shares

$1,714
0.0% of portfolio

View Full List

About VBI Vaccines Inc

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

More about VBIV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account